Teewinot’s Irish subsidiary has been granted a fourth patent for a pharmaceutical cannabinoid manufacturing technique which it says saves both time and money.
Japanese glass and chemical company Central Glass has found a swift
route into the contract manufacturing market for active
pharmaceutical ingredients (APIs) in Europe via the purchase of
Girindus' facility in Halle-Kuensebeck.
Fine chemicals firm Degussa has decided to spin off its NCN
business in Bavaria into a new legal entity known as AlzChem
Trostberg, hoping a new name will lead to new opportunities.
Chemical Synthesis Services of Northern Ireland has acquired a
controlling interest in Albachem, a company specialising in peptide
and protein synthesis based in West Lothian, Scotland.
Speciality chemical company Rohm and Haas has created a new
business unit, Advanced Biosciences, that specialises in the
production and purification of biopharmaceuticals. The new unit is
well placed to address the shortfall in production...